Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
30.79
-1.04 (-3.27%)
At close: May 29, 2026, 4:00 PM EDT
30.76
-0.03 (-0.10%)
After-hours: May 29, 2026, 6:26 PM EDT
Phibro Animal Health Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Phibro Animal Health stock has a consensus rating of "Hold" and an average price target of $45.6. The average 1-year stock price forecast is 48.10% higher than the current stock price, while the lowest is $38 (+23.42%) and the highest is $58 (+88.37%).
Price Target: $45.6 (+48.10%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Phibro Animal Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Hold Reiterates $62 → $44 | Hold | Reiterates | $62 → $44 | +42.90% | May 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $58 | Buy | Maintains | $58 | +88.37% | Feb 9, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $49 | Hold | Maintains | $45 → $49 | +59.14% | Feb 6, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $32 → $38 | Sell | Reiterates | $32 → $38 | +23.42% | Feb 5, 2026 |
Financial Forecast
Revenue This Year
1.53B
from 1.30B
Increased by 17.88%
Revenue Next Year
1.58B
from 1.53B
Increased by 3.34%
EPS This Year
3.13
from 1.19
Increased by 163.25%
EPS Next Year
3.41
from 3.13
Increased by 8.86%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.6B | 1.6B | |||
| Avg | 1.5B | 1.6B | |||
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 22.4% | 6.9% | |||
| Avg | 17.9% | 3.3% | |||
| Low | 11.8% | -1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.27 | 3.65 | |||
| Avg | 3.13 | 3.41 | |||
| Low | 2.95 | 3.18 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 174.4% | 16.6% | |||
| Avg | 163.2% | 8.9% | |||
| Low | 147.9% | 1.4% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.